The decision to abandon development of the oral selective oestrogen receptor degrader (SERD) comes after an ... patients who have discontinues aromatase inhibitor therapy due to toxicity.

[5] Early adjuvant therapy -- replacing tamoxifen therapy with aromatase inhibitor therapy during the first 5 years after surgery; Early sequential adjuvant therapy -- sequencing of tamoxifen and ...

"CDK4/6 inhibitors have been a critical addition to standard endocrine therapy with aromatase inhibitors, and if progression occurs, combining a SERD with a CDK4/6 inhibitor can be beneficial ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

Aromatase inhibitors are able to block the biosynthesis of estrogen—a process that is essential in bone maturation, growth-plate fusion, and cessation of longitudinal growth. Aromatase ...

Burnett-Bowie et al. investigated the efficacy and safety of the synthetic aromatase inhibitor anastrozole to treat hypogonadism in aging men. The study enrolled 88 men (60 years or older ...

such as injectable fulvestrant – sold by AZ as Faslodex and the only SERD approved for breast cancer – or aromatase inhibitors like letrozole, anastrozole, or exemestane. For the overall group ...

In the overall study population, median PFS was 5.6 months with imlunestrant -- a next-generation, brain-penetrant, oral selective ER degrader (SERD ... or after aromatase inhibitor therapy ...

Considering taking supplements to treat aromatase inhibitor induced arthralgia? Below is a list of common natural remedies used to treat or reduce the symptoms of aromatase inhibitor induced ...